Your location:Home > Products
Products
ReDura
 

 

 Material and Structure

• Synthetic biomaterial scaffold resembles microstructures of native dural matrices, and provides appropriate environment for recr-
  uitment, growth, and proliferation  of dural cells on scaffolds.

• Excellent biocompatible mesh facilitates cellular migration and growth, thus is able to repair and regenerate defective dura within
  a few months.

 



 Working Mechanism

• As a repair  material, the ReDuraTM patch can effectively address dural defects caused by tumor ablations and traumatic injuries
  as well as maintain integrity of anatomical structure of the dura.

• With harmonic pace of degradation and regeneration,scaffold of the patch can be gradually absorbed by human body within a few
  months after operation and eventually replaced by new-born dural layers.

• Full degradation and recovery of dural membrane can avoids immuno-rejection of the implanted device caused by long-term exis-
  tence of materials.  

 



 Patented Technology and Quality Guarantee

• Pending PCT international patent under protection of intellectual property laws and regulations of designed countries.

• Stable mass-production process, effective implementation of ISO13485 Quality Management System.

 



 Pre-clinical Animal Studies: 3-month Post-implantation
                                                                                                
                                                                                                  • General Appearance

           

                                            
                                  Surgical operation of ReDuraTM patch in a              In ReDuraTM  groups, new-born membrane
                                  defective dura model                                                   took place in defects and scaffold materials 
                                                                                                                           degraded mostly (green arrows);however, in 
                                                                                                                           controls, partial dural was regrown with slow
                                                                                                                           degradation of scaffold (blue arrows).       

                                                                                                  Adhesion Analysis

                                                                    
                                   ReDuraTM  group: smooth  surface of  brain             Control group: close adhesion of material 
                                   tissue   with  no  adhesion  to  implanted                  to brain tissue
                                   material

                                                                                                Histological Evaluation
 
                                             
                                  
ReDuraTMgroup: implant became disconti-              Control group: implant was still integrated 
                                   nuously distributed  and  exhibited a loose              and  strip-shaped;  some fibroblasts grew
                                  fine mesh-shaped structure with fibroblast               into  the implant; a  few  calcification spots
                                  and collagen fibers growing in a pattern of                were seen(in the upper right corner of this
                                  ribbon.                                                                                picture).




 Clinical Studies: ReDuraTM Patches in Patients
 
     
ReDuraTM(4×6cm ) was laid
and  sutured  onto  the  dural
of a patient.
  The patient had glioma.  Pre-
operative CT image showed
operative CT image showed
glioma.
 
  Post-operative CT scanning
( Day  3 ).  The  glioma  was
removed and no CSF leakage
was found.
  Post-operative   CT  scanning
(Day7). No CSF leakage was
urther  confirmed  and  rapid
growth of "neo-dural" tissues
was seen.

Medprin Biotech L.L.C.
1421 East Firestone Blvd, Suite 400, La Mirada, CA 90638, USA.    Website: www.medprin.com;    E-mail: sales@medprin.com
Tel: +1-562-239-2150;    Fax: +1-562-724-9828